281 related articles for article (PubMed ID: 27650969)
1. Chromosomal microarray testing in adults with intellectual disability presenting with comorbid psychiatric disorders.
Wolfe K; Strydom A; Morrogh D; Carter J; Cutajar P; Eyeoyibo M; Hassiotis A; McCarthy J; Mukherjee R; Paschos D; Perumal N; Read S; Shankar R; Sharif S; Thirulokachandran S; Thygesen JH; Patch C; Ogilvie C; Flinter F; McQuillin A; Bass N
Eur J Hum Genet; 2016 Jan; 25(1):66-72. PubMed ID: 27650969
[TBL] [Abstract][Full Text] [Related]
2. Neurodevelopmental risk copy number variants in adults with intellectual disabilities and comorbid psychiatric disorders.
Thygesen JH; Wolfe K; McQuillin A; Viñas-Jornet M; Baena N; Brison N; D'Haenens G; Esteba-Castillo S; Gabau E; Ribas-Vidal N; Ruiz A; Vermeesch J; Weyts E; Novell R; Buggenhout GV; Strydom A; Bass N; Guitart M; Vogels A
Br J Psychiatry; 2018 May; 212(5):287-294. PubMed ID: 29693535
[TBL] [Abstract][Full Text] [Related]
3. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC
Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909
[TBL] [Abstract][Full Text] [Related]
4. Copy number variants are frequent in genetic generalized epilepsy with intellectual disability.
Mullen SA; Carvill GL; Bellows S; Bayly MA; Trucks H; Lal D; Sander T; Berkovic SF; Dibbens LM; Scheffer IE; Mefford HC
Neurology; 2013 Oct; 81(17):1507-14. PubMed ID: 24068782
[TBL] [Abstract][Full Text] [Related]
5. Effects of pathogenic CNVs on physical traits in participants of the UK Biobank.
Owen D; Bracher-Smith M; Kendall KM; Rees E; Einon M; Escott-Price V; Owen MJ; O'Donovan MC; Kirov G
BMC Genomics; 2018 Dec; 19(1):867. PubMed ID: 30509170
[TBL] [Abstract][Full Text] [Related]
6. A cohort study of neurodevelopmental disorders and/or congenital anomalies using high resolution chromosomal microarrays in southern Brazil highlighting the significance of ASD.
Chaves TF; Ocampos M; Barbato IT; de Camargo Pinto LL; de Luca GR; Barbato Filho JH; Bernardi P; Costa Netto Muniz Y; Francesca Maris A
Sci Rep; 2024 Feb; 14(1):3762. PubMed ID: 38355898
[TBL] [Abstract][Full Text] [Related]
7. New insights in the interpretation of array-CGH: autism spectrum disorder and positive family history for intellectual disability predict the detection of pathogenic variants.
Cappuccio G; Vitiello F; Casertano A; Fontana P; Genesio R; Bruzzese D; Ginocchio VM; Mormile A; Nitsch L; Andria G; Melis D
Ital J Pediatr; 2016 Apr; 42():39. PubMed ID: 27072107
[TBL] [Abstract][Full Text] [Related]
8. High-resolution chromosomal microarray analysis for copy-number variations in high-functioning autism reveals large aberration typical for intellectual disability.
Werling AM; Grünblatt E; Oneda B; Bobrowski E; Gundelfinger R; Taurines R; Romanos M; Rauch A; Walitza S
J Neural Transm (Vienna); 2020 Jan; 127(1):81-94. PubMed ID: 31838600
[TBL] [Abstract][Full Text] [Related]
9. Genomic Disorders in Psychiatry-What Does the Clinician Need to Know?
Lowther C; Costain G; Baribeau DA; Bassett AS
Curr Psychiatry Rep; 2017 Sep; 19(11):82. PubMed ID: 28929285
[TBL] [Abstract][Full Text] [Related]
10. Copy Number Variations in a Cohort of 420 Individuals with Neurodevelopmental Disorders From the South of Brazil.
Chaves TF; Baretto N; Oliveira LF; Ocampos M; Barbato IT; Anselmi M; De Luca GR; Barbato Filho JH; Pinto LLC; Bernardi P; Maris AF
Sci Rep; 2019 Nov; 9(1):17776. PubMed ID: 31780800
[TBL] [Abstract][Full Text] [Related]
11. Integration of genetic, transcriptomic, and clinical data provides insight into 16p11.2 and 22q11.2 CNV genes.
Vysotskiy M; Zhong X; Miller-Fleming TW; Zhou D; ; ; ; Cox NJ; Weiss LA
Genome Med; 2021 Oct; 13(1):172. PubMed ID: 34715901
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic services.
Roberts JL; Hovanes K; Dasouki M; Manzardo AM; Butler MG
Gene; 2014 Feb; 535(1):70-8. PubMed ID: 24188901
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.
Ho KS; Wassman ER; Baxter AL; Hensel CH; Martin MM; Prasad A; Twede H; Vanzo RJ; Butler MG
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941670
[TBL] [Abstract][Full Text] [Related]
14. Application of chromosome microarray analysis in patients with unexplained developmental delay/intellectual disability in South China.
Wang R; Lei T; Fu F; Li R; Jing X; Yang X; Liu J; Li D; Liao C
Pediatr Neonatol; 2019 Feb; 60(1):35-42. PubMed ID: 29631977
[TBL] [Abstract][Full Text] [Related]
15. A genome wide survey supports the involvement of large copy number variants in schizophrenia with and without intellectual disability.
Derks EM; Ayub M; Chambert K; Del Favero J; Johnstone M; MacGregor S; Maclean A; McKechanie AG; McRae AF; Moran JL; Pickard BS; Purcell S; Sklar P; StClair DM; Wray NR; Visscher PM; Blackwood DH
Am J Med Genet B Neuropsychiatr Genet; 2013 Dec; 162B(8):847-54. PubMed ID: 24115684
[TBL] [Abstract][Full Text] [Related]
16. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis.
Williams NM; Zaharieva I; Martin A; Langley K; Mantripragada K; Fossdal R; Stefansson H; Stefansson K; Magnusson P; Gudmundsson OO; Gustafsson O; Holmans P; Owen MJ; O'Donovan M; Thapar A
Lancet; 2010 Oct; 376(9750):1401-8. PubMed ID: 20888040
[TBL] [Abstract][Full Text] [Related]
17. The contribution of copy number variants to psychiatric symptoms and cognitive ability.
Mollon J; Almasy L; Jacquemont S; Glahn DC
Mol Psychiatry; 2023 Apr; 28(4):1480-1493. PubMed ID: 36737482
[TBL] [Abstract][Full Text] [Related]
18. Genotype-phenotype associations in children with copy number variants associated with high neuropsychiatric risk in the UK (IMAGINE-ID): a case-control cohort study.
Chawner SJRA; Owen MJ; Holmans P; Raymond FL; Skuse D; Hall J; van den Bree MBM
Lancet Psychiatry; 2019 Jun; 6(6):493-505. PubMed ID: 31056457
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea.
Jang W; Kim Y; Han E; Park J; Chae H; Kwon A; Choi H; Kim J; Son JO; Lee SJ; Hong BY; Jang DH; Han JY; Lee JH; Kim SY; Lee IG; Sung IK; Moon Y; Kim M; Park JH
Ann Lab Med; 2019 May; 39(3):299-310. PubMed ID: 30623622
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility and cost-effectiveness analysis of chromosome testing concomitant with chromosomal microarray of patients with constitutional disorders in a U.S. academic medical center.
Su M; Page S; Haag M; Swisshelm K; Hennerich D; Graw S; LeRoux J; Brzeskiewicz P; Svihovec S; Bao L
J Genet Couns; 2022 Apr; 31(2):364-374. PubMed ID: 34397147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
